NFE2L2 and metabolic dysfunction-associated steatohepatitis: These properties may be related to Nrf2/HO-1 pathway activation and TLR4/NF-kB mediated inflammatory pathway inhibition, which may attenuate NASH associated altered lipid profile, liver damage, and apoptosis.